Connect Biopharma Limite...

NASDAQ: CNTB · Real-Time Price · USD
1.92
-0.13 (-6.34%)
At close: Aug 18, 2025, 10:40 AM

Connect Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
78.23M 105.66M 80.37M 268.02M
Short-Term Investments
15.48M 12.65M 74.67M 677.10
Long-Term Investments
n/a n/a 9.6M n/a
Other Long-Term Assets
33K 132K 34.62K 2.95M
Receivables
1.05M 351K n/a 7.41M
Inventory
n/a n/a -6.42M -6.74K
Other Current Assets
53K 54K n/a n/a
Total Current Assets
96.96M 122.55M 158.46M 275.44M
Property-Plant & Equipment
4.24M 4.74M 5.47M 12.9M
Goodwill & Intangibles
53K 62K 3.22M 87.93K
Total Long-Term Assets
4.32M 4.82M 18.55M 15.94M
Total Assets
101.28M 125.89M 177.01M 291.39M
Account Payables
342K 7.66M 11.94M 12.73M
Deferred Revenue
164K 13.32M n/a n/a
Short-Term Debt
154K n/a n/a n/a
Other Current Liabilities
3.19M 2.05M 2.69M 5.15M
Total Current Liabilities
8.46M 25.29M 15.89M 18.01M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
632K n/a n/a 784K
Total Long-Term Liabilities
656K 585K 911.83K 810.73K
Total Liabilities
9.12M 24.85M 16.81M 18.82M
Total Debt
178K 465K 437.88K 124.52K
Common Stock
10K 10K 9.64K 10.36K
Retained Earnings
-345.36M -329.73M -463.76M -373.43M
Comprehensive Income
-1.67M 11.85M 10.39M -6.48M
Shareholders Equity
92.17M 101.04M -463.76M 272.57M
Total Investments
15.48M 12.64M 84.27M 677.10